advertisement
11.4 Prostaglandins (17)
Showing records 1 to 17
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins13142 Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology 2005; 112: 2123-2130
13213 A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or
Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV
Journal of Glaucoma 2005; 14: 392-399
12989 The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Experimental Eye Research 2005; 81: 610-615
13175 Modulation of conventional outflow facility by the adenosine A1 agonist N6-cyclohexyladenosine
Crosson CE; Sloan CF; Yates PW
Investigative Ophthalmology and Visual Science 2005; 46: 3795-3799
13018 Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice
Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
Investigative Ophthalmology and Visual Science 2005; 46: 4571-4577
13022 In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Investigative Ophthalmology and Visual Science 2005; 46: 4594-4599
13042 Bimatoprost-induced periocular skin hyperpigmentation: histopathological study
Kapur R; Osmanovic S; Toyran S; Edward DP
Archives of Ophthalmology 2005; 123: 1541-156
13008 Intraocular metabolites of isopropyl unoprostone
Numaga J; Koseki N; Kaburaki T; Kawashima H; Tomita G; Araie M
Current Eye Research 2005; 30: 909-913
12608 Intraocular pressure, visual field and shape of optic disc after one year of latanoprost monotherapy
Ogata H; Shoji N; Shimizu K; Takase M; Arimoto A; Nakazawa N; Suzuki M; Tomioka T
Japanese Journal of Clinical Ophthalmology 2005; 59: 943-947
13124 The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice
Ota T; Aihara M; Narumiya S; Araie M
Investigative Ophthalmology and Visual Science 2005; 46: 4159-4163
13104 Influence of prostaglandins on aqueous humour dynamics and intraocular pressure
Raber T
Klinische Monatsblätter für Augenheilkunde 2005; 222: 802-806
13110 Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells
Thieme H; Steinhausen K; Ottlecz A; Lambrou GN; Strauss O; Wiederholt M; Rosenthal R
Ophthalmic Research 2005; 37: 293-300
13007 Effect of latanoprost on cultured porcine corneal stromal cells
Wu KY; Wang HZ; Hong SJ
Current Eye Research 2005; 30: 871-879
13006 The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure
Yang H; Avila MY; Peterson-Yantorno K; Coca-Prados M; Stone RA; Jacobson KA; Civan MM
Current Eye Research 2005; 30: 747-754
12610 Incidental corneal pseudodendrite recurrence upon reinitiation of latanoprost
Besada E; Reynolds S
Clinical and Refractive Optometry 2005; 16: 233-238
12609 Bimatoprost: Mechanism of ocular surface hyperemia associated with topical therapy
Chen J; Dinh T; Woodward DF; Holland JM; Yuan Y-D; Lin T-H; Wheeler LA
Cardiovascular Drug Reviews 2005; 23: 231-246
12607 Efficacy and safety of bimatoprost for patients with open angle glaucoma or ocular hypertension in the Asia Pacific Region
Rait JL; Low CH; Leuenberger EU; Singh P; O'Rourke MT; Romani R; Wanichwecha Rungruang B
Asian Journal of Ophthalmology 2005; 7: 82-90
